Perspectives in the use of newer bisphosphonates in the management of established osteoporosis.

Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.

Long-term use of bisphosphonates in osteoporosis.

Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials.

The hepatorenal syndrome--newer perspectives.

Bisphosphonates in the treatment of HIV-related osteoporosis.

The use of bisphosphonates in pediatrics.

$Risk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications.$
Risk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications.

The use of bisphosphonates in children: review of the literature and guidelines for dental management.

Newer Perspectives of Childhood Asthma.

Treatment of post-menopausal osteoporosis: beyond bisphosphonates.

Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.

The management of osteoporosis.

Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?

Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum.

Bisphosphonates and glucocorticoid-induced osteoporosis: cons.

Propranolol and newer antihypertensive drugs in the management of hypertension.

Newer algorithms in bradycardia management.

Recent advances in the management of osteoporosis.

The use of newer high translucency zirconia in aesthetic zone.

Rationale for the use of bisphosphonates in bone metastases.

Sclerostin Inhibition in the Management of Osteoporosis.

Established and forthcoming drugs for the treatment of osteoporosis.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates.

Suggest Documents

Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.

Long-term use of bisphosphonates in osteoporosis.

Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials.

The hepatorenal syndrome--newer perspectives.

Bisphosphonates in the treatment of HIV-related osteoporosis.

The use of bisphosphonates in pediatrics.

Risk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications.

The use of bisphosphonates in children: review of the literature and guidelines for dental management.

Newer Perspectives of Childhood Asthma.

Treatment of post-menopausal osteoporosis: beyond bisphosphonates.

Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.

The management of osteoporosis.

Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?

Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum.

Bisphosphonates and glucocorticoid-induced osteoporosis: cons.

Propranolol and newer antihypertensive drugs in the management of hypertension.

Newer algorithms in bradycardia management.

Recent advances in the management of osteoporosis.

The use of newer high translucency zirconia in aesthetic zone.

Rationale for the use of bisphosphonates in bone metastases.

Sclerostin Inhibition in the Management of Osteoporosis.

Established and forthcoming drugs for the treatment of osteoporosis.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates.

Perspectives in the use of newer bisphosphonates in the management of established osteoporosis.

Recommend Documents

Follow Us